MedTrace Logo

The MASS COMM Post-Randomization Phase Cohort Study

NCT02072421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2879

Last updated 2015-04-07

Study results available
· View outcomes & findings →

Summary

The primary objective of the Post-Randomization Phase Cohort Study is to continue to assess the safety of non-emergency PCI performed at hospitals without cardiac surgery on-site in patients with myocardial ischemia (other than ST-segment elevation myocardial infarction \[STEMI\]).

Conditions

Interventions

PROCEDURE

PCI

Sponsors & Collaborators

  • Brockton Hospital

    collaborator OTHER

  • Good Samaritan Hospital Medical Center, New York

    collaborator OTHER

  • Norwood Hospital

    collaborator OTHER

  • Holy Family Hospital, Methuen, MA

    collaborator OTHER

  • Lawrence General Hospital

    collaborator UNKNOWN

  • Lowell General Hospital

    collaborator OTHER

  • Melrose Wakefield Hospital

    collaborator UNKNOWN

  • Metro West Medical Center

    collaborator OTHER

  • Saints Memorial Medical Center

    collaborator UNKNOWN

  • South Shore Hospital

    collaborator OTHER

  • Baim Institute for Clinical Research

    lead OTHER

Principal Investigators

  • Alice K Jacobs, MD · Boston University School of Medicine , Boston Medical Center

  • Laura Mauri, MD · Brigham and Women's Hospital

  • Sharon-Lise Normand, PhD · Harvard Medical School (HMS and HSDM)

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-09-30
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02072421 on ClinicalTrials.gov